Suprachoroidal triamcinolone for macular edema from non-infectious uveitis after failed sub-Tenon injections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants receive a baseline eye exam including vision testing, slit-lamp exam, and OCT retinal imaging. They then receive one suprachoroidal triamcinolone injection under topical anesthetic in a sterile operating-room setting with standard monitoring. Follow-up visits occur about 1 month and 3 months after treatment with repeat vision tests and OCT scans to measure change in visual acuity and retinal thickness. Participants are instructed to contact the clinic for new pain, redness, floaters, or worsening vision.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Non-infectious uveitis complicated with macular edema
* Uveitic macular edema of less than four months' duration
* Macular edema persisted despite lack of intra-ocular inflammation
* No response to posterior sub-Tenon triamcinolone acetonide injections

Exclusion Criteria:

* Those with epiretinal membrane-associated macular edema
* Below 18 years

Where it's running

• Ibn Al-Haitham Eye Teaching Hospital
  Baghdad, Iraq Recruiting

Study contacts

• Study coordinator: Mohammed Suhail Al-Salam
• Email: mohammedsuhail@uomustansiriyah.edu.iq
• Phone: +964 790 183 6367

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• TRX103 cell therapy for active non-infectious uveitis

  This early-phase trial tests a single infusion of TRX103 to see if it is safe and tolerable for adults with active non-infectious uveitis.

  Recruiting Phase 1 Stanford University · Palo Alto, California · NCT07427628

• Minimal vitrectomy for epiretinal membrane

  This trial tests whether a minimal vitrectomy technique helps adults with idiopathic epiretinal membrane improve vision and slow cataract progression compared with conventional vitrectomy.

  Recruiting Peking Union Medical College Hospital · Beijing, Beijing Municipality · NCT07019896

• Clear twin block for growing patients with class II malocclusion

  This study tests whether wearing a clear twin block appliance for 3 months helps correct dento-skeletal differences in kids aged 9–12 with Class II Division 1 malocclusion.

  Recruiting University of Baghdad · Baghdad, Baghdad Governorate · NCT07924982

• Accelerating tooth movement with MOP, prostaglandin E1, and calcitriol

  This study tests whether micro-osteoperforations, prostaglandin E1 injections, or calcitriol injections can speed up orthodontic tooth movement in young adults with moderate lower-front crowding.

  Recruiting at 2 sites Phase 2 University of Baghdad · Baghdad, Baghdad Governorate and 1 other locations · NCT07842120

• EHBM-based approach to boost collegians' oral health habits

  This study tests whether an Expanded Health Belief Model–based program can improve brushing, flossing, and dental visits among undergraduate students aged 18-25.

  Recruiting University of Baghdad · Basra, Basra Governorate · NCT07715773

• 3D printed reverse twin block to treat Class III malocclusion in growing kids

  This trial tests whether a 3D-printed reverse twin block can better correct maxillary deficiency in children with Class III alignment compared with the conventional appliance over six months.

  Recruiting University of Baghdad · Baghdad · NCT07710391

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.